-+ 0.00%
-+ 0.00%
-+ 0.00%

GAIN THERAPEUTICS - TO INITIATE PHASE 2 REXACERACT TRIAL IN Q1 2027 - SEC FILING

Reuters·10/01/2026 13:18:00

Please log in to view news